About Index Trending news
Analyze
Pricing
Promethera Biosciences

Promethera Biosciences

Work at Promethera Biosciences? Add yourself to this profile

Promethera Biosciences

Promethera Biosciences is a biopharmaceutical company focused on cell therapyproducts to treat liver diseases.
Edit Profile
More info

Elsewhere

Companies in the same industry

Complexa Complexa Clearside BioMedical, Inc. Clearside BioMedical, Inc. Mersana Therapeutics Mersana Therapeutics Hengrui Therapeutics, Inc. Hengrui Therapeutics, Inc. Allinaire Therapeutics Allinaire Therapeutics Vividion Therapeutics Vividion Therapeutics Atterx Biotherapeutics Atterx Biotherapeutics ArGEN-X ArGEN-X CoDa Therapeutics, Inc. CoDa Therapeutics, Inc. 3-V Biosciences 3-V Biosciences

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
Latest funding Show all
Venture capital (Series C)
€10,000,000
Mitsubishi UFJ Capital, Vesalius Biocapital Partners, Boehringer Ingelheim Venture Fund, +4
Venture capital (Series C)
$31,444,456
Employees

Team size

10+
Locations
HQ
Belgium
Headquarters
€10,000,000 Venture capital (Series C)
businesswire

Promethera Biosciences Raises EUR 10 Million in a Series C-extension Financing to Advance its Broad Product Pipeline in Liver Diseases | Business Wire

Promethera Biosciences
Promethera Biosciences